Veriti Management LLC Acquires 34 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Veriti Management LLC grew its position in shares of Mettler-Toledo International Inc. (NYSE:MTDGet Rating) by 5.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 706 shares of the medical instruments supplier’s stock after acquiring an additional 34 shares during the period. Veriti Management LLC’s holdings in Mettler-Toledo International were worth $969,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of MTD. Norges Bank purchased a new position in shares of Mettler-Toledo International during the 4th quarter worth approximately $318,096,000. SkyView Investment Advisors LLC grew its stake in shares of Mettler-Toledo International by 41,529.7% in the 4th quarter. SkyView Investment Advisors LLC now owns 88,255 shares of the medical instruments supplier’s stock worth $384,000 after buying an additional 88,043 shares during the last quarter. Moors & Cabot Inc. purchased a new stake in shares of Mettler-Toledo International in the 3rd quarter worth approximately $51,000. State Street Corp grew its stake in shares of Mettler-Toledo International by 2.8% in the 4th quarter. State Street Corp now owns 1,004,301 shares of the medical instruments supplier’s stock worth $1,704,510,000 after buying an additional 27,181 shares during the last quarter. Finally, Ensign Peak Advisors Inc grew its stake in shares of Mettler-Toledo International by 77.2% in the 4th quarter. Ensign Peak Advisors Inc now owns 61,228 shares of the medical instruments supplier’s stock worth $103,917,000 after buying an additional 26,667 shares during the last quarter. Hedge funds and other institutional investors own 93.88% of the company’s stock.

In other news, Director Wah-Hui Chu sold 300 shares of the stock in a transaction on Friday, May 13th. The stock was sold at an average price of $1,268.00, for a total transaction of $380,400.00. Following the transaction, the director now directly owns 3,075 shares of the company’s stock, valued at approximately $3,899,100. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 948 shares of the stock in a transaction on Thursday, May 12th. The shares were sold at an average price of $1,195.60, for a total value of $1,133,428.80. Following the transaction, the insider now directly owns 505 shares in the company, valued at $603,778. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,571 shares of company stock worth $48,377,720. Company insiders own 2.80% of the company’s stock.

MTD has been the topic of several recent research reports. Wells Fargo & Company upgraded Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and cut their price target for the stock from $1,600.00 to $1,410.00 in a research note on Monday, April 25th. StockNews.com initiated coverage on Mettler-Toledo International in a research note on Thursday, March 31st. They issued a “buy” rating on the stock. Finally, The Goldman Sachs Group downgraded Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 price target on the stock. in a research note on Thursday, March 10th.

Shares of MTD opened at $1,101.73 on Thursday. The business’s fifty day simple moving average is $1,252.55 and its two-hundred day simple moving average is $1,394.02. The company has a current ratio of 1.20, a quick ratio of 0.79 and a debt-to-equity ratio of 20.89. Mettler-Toledo International Inc. has a 12 month low of $1,082.78 and a 12 month high of $1,714.75. The company has a market cap of $25.05 billion, a price-to-earnings ratio of 32.36, a P/E/G ratio of 1.50 and a beta of 1.06.

Mettler-Toledo International (NYSE:MTDGet Rating) last issued its earnings results on Thursday, May 5th. The medical instruments supplier reported $7.87 EPS for the quarter, beating the consensus estimate of $7.32 by $0.55. Mettler-Toledo International had a return on equity of 540.97% and a net margin of 20.82%. The business had revenue of $897.80 million for the quarter, compared to the consensus estimate of $868.08 million. During the same period last year, the business posted $6.56 EPS. The company’s revenue was up 11.6% compared to the same quarter last year. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 38.35 EPS for the current year.

Mettler-Toledo International Profile (Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Want More Great Investing Ideas?

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.